PROPHETIRAE
LIVE

Serial Number

79430224

Owner

ONCOHOST LTD

Attorney

Roy D. Gross

Filing Date

Jun 17, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PROPHETIRAE Trademark

Serial Number: 79430224

PROPHETIRAE is a trademark filed by ONCOHOST LTD on June 17, 2025. The trademark is classified under Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

ONCOHOST LTD (9 trademarks)

Hamelacha St. 3

Entity Type: 99

Trademark Details

Filing Date

June 17, 2025

Registration Date

Not Registered

Published for Opposition

June 9, 2026

Goods & Services

Medical analysis services relating to the treatment of persons; medical analysis services for the prediction of response to cancer treatment; medical analysis services for clinical outcomes associated with cancer treatment; medical analysis services for the prediction of side effects of cancer treatment; medical analysis services for the prediction of treatment side effects in a cancer patient; medical analysis services for identification of new drug targets for cancer treatment; medical analysis services for identification of new drug targets for the treatment of cancer drug side effects; medical analysis services for the prediction of response to cancer treatment based on computational analysis of patient's proteins; medical analysis services relating to the treatment of persons for predicting drug side effects based on computational analysis of patient's proteins; medical analysis services relating to the treatment of persons for discovering new drug targets for overcoming cancer drug resistance, based on computational analysis of patient's proteins; medical analysis services for discovering new drug targets for overcoming side effects associated with cancer treatment, based on computational analysis of patient's proteins; medical analysis services to support decision-making regarding the treatment of cancer patients; medical analysis services for the prediction of patients' response to cancer treatment and the identification of associated biological mechanisms; medical analysis services for the prediction of cancer treatment side effects and the identification of associated biological mechanisms.

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 9, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 9, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 3, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 13, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 11, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 11, 2026 TROA
REFUSAL PROCESSED BY IB
Jan 1, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 17, 2025 RFCS
REFUSAL PROCESSED BY MPU
Dec 16, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 6, 2025 RFCR
NON-FINAL ACTION WRITTEN
Nov 5, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 4, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 15, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 15, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 14, 2025 REPR